Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
53,788,752
-
Total 13F shares
-
3,347,909
-
Share change
-
+543,290
-
Total reported value
-
$3,849,710
-
Price per share
-
$1.15
-
Number of holders
-
13
-
Value change
-
+$624,784
-
Number of buys
-
3
-
Number of sells
-
1
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) as of Q4 2023
As of 31 Dec 2023 ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,347,909 shares of stock of the company.
Largest 10 holders included SPHERA FUNDS MANAGEMENT LTD., Ally Bridge Group (NY) LLC, Affinity Asset Advisors, LLC, Northeast Financial Consultants Inc, IEQ CAPITAL, LLC, FIDUCIARY TRUST CO, Kingsview Wealth Management, LLC, Claret Asset Management Corp, UBS Group AG, and BANK OF AMERICA CORP /DE/.
This table shows 13 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.